130 related articles for article (PubMed ID: 38175451)
1. Correction to: Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency.
Yu Y; Xu L; Xu T; Yang C; Bu Q; Zhang W; Zhao L; Xu Y; Jiang W
Clin Exp Nephrol; 2024 Feb; 28(2):179. PubMed ID: 38175451
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of entecavir for hepatitis B virus-associated glomerulonephritis with renal insufficiency.
Yu Y; Xu L; Xu T; Yang C; Bu Q; Zhang W; Zhao L; Xu Y; Jiang W
Clin Exp Nephrol; 2023 Aug; 27(8):680-686. PubMed ID: 37115381
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of tacrolimus and entecavir combination therapy in the treatment of hepatitis B virus-associated glomerulonephritis: a multi-center, placebo controlled, and single-blind randomized trial.
Xie XF; Xie BY; Zhang WH; Hou JH; Liu DL; Zhang L; Xu LX; Li ZL; Li RZ; Ye ZM
Ann Palliat Med; 2022 May; 11(5):1762-1773. PubMed ID: 35672893
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.
Wang L; Xie B; Zheng Q; Xu L; Ye Z
Rev Esp Enferm Dig; 2020 Nov; 112(11):843-849. PubMed ID: 33054304
[TBL] [Abstract][Full Text] [Related]
5. The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication.
Wang L; Ye Z; Liang H; Zhang B; Xu L; Feng Z; Liu S; Shi W
Am J Transl Res; 2016; 8(3):1593-600. PubMed ID: 27186284
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.
Liang J; Jiang MJ; Deng X; Xiao Zhou X
Hepat Mon; 2013; 13(6):e7862. PubMed ID: 24032045
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
Xiong QF; Zhong YD; Hu ZL; Yang YF
Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
[TBL] [Abstract][Full Text] [Related]
8. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
10. Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
Lim YS; Gwak GY; Choi J; Lee YS; Byun KS; Kim YJ; Yoo BC; Kwon SY; Lee HC
J Hepatol; 2019 Jul; 71(1):35-44. PubMed ID: 30876946
[TBL] [Abstract][Full Text] [Related]
11. Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report.
Kataoka H; Mochizuki T; Akihisa T; Kawasoe K; Kawachi K; Makabe S; Sawada A; Manabe S; Sato M; Amemiya N; Mitobe M; Akanuma T; Ito Y; Inoue T; Suzuki T; Matsui K; Moriyama T; Horita S; Ohara M; Honda K; Nitta K
Medicine (Baltimore); 2019 Jan; 98(2):e14014. PubMed ID: 30633192
[TBL] [Abstract][Full Text] [Related]
12. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients.
Suzuki F; Toyoda J; Katano Y; Sata M; Moriyama M; Imazeki F; Kage M; Seriu T; Omata M; Kumada H
J Gastroenterol Hepatol; 2008 Sep; 23(9):1320-6. PubMed ID: 18554238
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.
Shan C; Yin GQ; Wu P
J Med Case Rep; 2014 Aug; 8():281. PubMed ID: 25146249
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.
de Man RA; Wolters LM; Nevens F; Chua D; Sherman M; Lai CL; Gadano A; Lee Y; Mazzotta F; Thomas N; DeHertogh D
Hepatology; 2001 Sep; 34(3):578-82. PubMed ID: 11526545
[TBL] [Abstract][Full Text] [Related]
16. A case of anti-GBM glomerulonephritis superimposed on HBV-associated membranous nephropathy.
Yamamoto T; Oseto S; Imakita N; Inada M; Fukunaga M
CEN Case Rep; 2013 Nov; 2(2):239-247. PubMed ID: 28509304
[TBL] [Abstract][Full Text] [Related]
17. Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection.
Kanada A; Takehara T; Ohkawa K; Kato M; Tatsumi T; Miyagi T; Sakamori R; Yamaguchi S; Uemura A; Kohga K; Sasakawa A; Hikita H; Kawamura K; Kanto T; Hiramatsu N; Hayashi N
Hepatol Res; 2008 Jun; 38(6):622-8. PubMed ID: 18070052
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.
Yuan Y; Iloeje UH; Hay J; Saab S
J Manag Care Pharm; 2008; 14(1):21-33. PubMed ID: 18240879
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis of the clinical efficacy of live bifidobacterium bacteria preparation combined with entecavir in the treatment of hepatitis B virus-related cirrhosis].
Chen H; Yuan HX; Li XH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):258-264. PubMed ID: 37137851
[No Abstract] [Full Text] [Related]
20. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
